In a move that will reverberate through the NIH extramural community, the NIH announced Friday afternoon how they intend to deal with the massive number of grant applications that were submitted in the days before and during the 16-day government shutdown.
At 12:25 am this morning, President Obama signed legislation ending the 2013 federal fiscal standoff and opening the government after a 16-day shutdown. Minutes later, the Office of Personnel Management sent out an email notifying federal employees that they "are expected to return for work on their next regularly scheduled work day."
There's only one place this weekend where you could crochet proteins, make a laser phonograph, crowd source a science fraud detector, and build a machine that sorts candy by color (a flow confectionometer?). Anyone with an interest in science and a playful streak can sign up to join a two day "science hacker" community in Boston this weekend at Harvard Northwest Building for free (thanks to sponsors like the ASCB), contributing to projects or coming up with their own.
Like a kid hovering over an ant with a magnifying glass, you can easily fry a worm with a microscope. But if you could do it without zapping the subjects, long exposure imaging would be immensely helpful for studying a cell process like development in a living Caenorhabditis elegans embryo. In a pair of just published papers—one in Nature Biotechnology yesterday and another in Nature Methods on October 6—Hari Shroff, tenure-track investigator at the NIH, unveiled a pair of new microscopes that offer an alternative solution to the problem of light-blasted subjects.
Grace Groovy of the International Journal of Cancer and Tumor would be happy to publish your nonsensical data, Science Magazine news reporter John Bohannon discovered. But that journal wasn't the exception. In a 15-month investigation, Bohannon concocted a bogus paper that he fed into a program that randomly generated bogus variations from bogus researchers at various bogus institutions which he then submitted to 304 open-access journals.
A senior researcher who can't get an answer from a shutdown NIH about a proposed clinical trial on a neurodegenerative disease, a Nobel Prize-winning scientist who fears that a generation of innovators will be lost, and a young investigator wearied at the lab by endless funding cuts and frustrated at home by the halt to promising research into a genetic disorder that affects her daughter
Two longtime ASCB members, Randy Schekman of the University of California, Berkeley, and James Rothman of Yale University, have won the 2013 Nobel Prize in Physiology or Medicine for their discoveries of how molecules move through the cell in vesicles and fuse to target membranes in a process known as "trafficking."
ASCB member Pascale Cossart of the Institut Pasteur in Paris won the 2013 International Balzan Prize, worth 750,000 Swiss francs (roughly $800,000), for her work on the molecular biology of pathogenic bacteria and their interaction with host cells. Speaking for the Balzan Foundation, Peter Suter, honorary vice president of the Swiss Academy of Medical Sciences, said, "Her research has provided very significant insights into the mechanisms underlying infectious diseases and how they might be combatted."
Just hours before the government may close down, federal employees around the world are waiting to hear if they will have to go to work in the morning. The question of the day in government buildings is which employees will be declared "essential" or "nonessential." Essential employees must show up for work even if the government is closed.
In a city where bikes outnumber cars and even people, more than 900 scientists dodged bicycles as they picked their way to the conference center for the 2013 EMBO meeting in Amsterdam. Kai Simons, Director Emeritus and Research Group Leader of the Max Planck Institute-CBG in Dresden, opened the meeting last Saturday, October 21. His talk that extended his pioneering research on lipid rafts in eukaryotic cell membranes toward bacteria with a new class of proteins called hopanoids that stand in for sterols on bacterial "liquid-ordered" membranes.